Armistice Capital Lifted Adamas Pharmaceuticals (ADMS) Position by $5.00 Million; Valuation Declined; As Mastercard (MA) Market Valuation Rose, Force Capital Management Cut by $317,020 Its Position

November 15, 2017 - By Marie Mckinney

Robert Jaffe decreased its stake in Mastercard Incorporated (MA) by 7.84% based on its latest 2017Q2 regulatory filing with the SEC. Force Capital Management Llc sold 2,620 shares as the company’s stock rose 7.46% with the market. The hedge fund run by Robert Jaffe held 30,792 shares of the business services company at the end of 2017Q2, valued at $3.74 million, down from 33,412 at the end of the previous reported quarter. Force Capital Management Llc who had been investing in Mastercard Incorporated for a number of months, seems to be less bullish one the $158.75 billion market cap company. The stock increased 0.16% or $0.24 during the last trading session, reaching $149.95. About 58 shares traded. Mastercard Inc (NYSE:MA) has risen 24.16% since November 15, 2016 and is uptrending. It has outperformed by 7.46% the S&P500.

Armistice Capital Llc increased its stake in Adamas Pharmaceuticals Inc (ADMS) by 34.03% based on its latest 2017Q2 regulatory filing with the SEC. Armistice Capital Llc bought 294,000 shares as the company’s stock declined 13.31% while stock markets rallied. The institutional investor held 1.16M shares of the health care company at the end of 2017Q2, valued at $20.25 million, up from 864,000 at the end of the previous reported quarter. Armistice Capital Llc who had been investing in Adamas Pharmaceuticals Inc for a number of months, seems to be bullish on the $599.54 million market cap company. The stock decreased 8.58% or $2.47 on November 14, reaching $26.32. About shares traded. Adamas Pharmaceuticals Inc (NASDAQ:ADMS) has declined 0.40% since November 15, 2016 and is downtrending. It has underperformed by 17.10% the S&P500.




More news for Adamas Pharmaceuticals Inc (NASDAQ:ADMS) were recently published by: Benzinga.com, which released: “Adamas Pharma’s Gocovri Will Achieve ‘Blockbuster’ Status, Says Kerrisdale” on November 01, 2017. Fool.com‘s article titled: “Why Adamas Pharmaceuticals Inc. Jumped Higher Today” and published on October 30, 2017 is yet another important article.

Armistice Capital Llc, which manages about $784.66 million US Long portfolio, decreased its stake in Horizon Pharma Plc (NASDAQ:HZNP) by 30,000 shares to 820,000 shares, valued at $9.73 million in 2017Q2, according to the filing. It also reduced its holding in Antares Pharma Inc (NASDAQ:ATRS) by 3.00 million shares in the quarter, leaving it with 5.70 million shares, and cut its stake in Aveo Pharmaceuticals Inc (NASDAQ:AVEO).

Among 10 analysts covering Adamas Pharmaceuticals (NASDAQ:ADMS), 9 have Buy rating, 1 Sell and 0 Hold. Therefore 90% are positive. Adamas Pharmaceuticals had 25 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Adamas Pharmaceuticals Inc (NASDAQ:ADMS) has “Neutral” rating given on Thursday, April 28 by Mizuho. The firm has “Neutral” rating given on Thursday, May 12 by Mizuho. The stock of Adamas Pharmaceuticals Inc (NASDAQ:ADMS) has “Outperform” rating given on Tuesday, January 19 by Cowen & Co. The firm earned “Buy” rating on Thursday, August 31 by Piper Jaffray. Mizuho upgraded it to “Buy” rating and $22 target in Thursday, June 16 report. On Friday, November 3 the stock rating was maintained by Mizuho with “Buy”. As per Wednesday, November 8, the company rating was maintained by Noble Financial. Credit Suisse maintained the shares of ADMS in report on Thursday, December 24 with “Outperform” rating. Mizuho maintained the stock with “Buy” rating in Thursday, September 8 report. The stock of Adamas Pharmaceuticals Inc (NASDAQ:ADMS) has “Buy” rating given on Friday, August 25 by Mizuho.

Force Capital Management Llc, which manages about $1.19 billion and $91.94M US Long portfolio, upped its stake in Chipotle Mexican Grill Inc (NYSE:CMG) by 3,000 shares to 7,520 shares, valued at $3.13M in 2017Q2, according to the filing. It also increased its holding in Spdr S&P 500 Etf Tr (SPY) by 31,905 shares in the quarter, for a total of 90,568 shares, and has risen its stake in Visa Inc (NYSE:V).

Analysts await Mastercard Inc (NYSE:MA) to report earnings on January, 30. They expect $1.12 EPS, up 30.23% or $0.26 from last year’s $0.86 per share. MA’s profit will be $1.19B for 33.47 P/E if the $1.12 EPS becomes a reality. After $1.34 actual EPS reported by Mastercard Inc for the previous quarter, Wall Street now forecasts -16.42% negative EPS growth.

Investors sentiment decreased to 0.88 in Q2 2017. Its down 0.06, from 0.94 in 2017Q1. It dropped, as 48 investors sold MA shares while 480 reduced holdings. 108 funds opened positions while 357 raised stakes. 790.40 million shares or 0.23% less from 792.22 million shares in 2017Q1 were reported. Gsa Prns Ltd Liability Partnership reported 9,407 shares. Ssi Investment Management stated it has 0.04% of its portfolio in Mastercard Inc (NYSE:MA). Parametric Portfolio Associates Limited Liability holds 0.43% or 2.88 million shares in its portfolio. Azimuth Capital Lc reported 4,735 shares. Riverpark Advsrs Limited Liability Co reported 37,803 shares. Laurion Capital Limited Partnership holds 245,415 shares or 0.16% of its portfolio. Captrust Fin Advisors holds 0.01% or 1,414 shares in its portfolio. Brinker reported 0.33% in Mastercard Inc (NYSE:MA). Mckinley Carter Wealth invested in 0.15% or 2,830 shares. Fred Alger Management invested in 96 shares. Bristol John W And New York holds 712,022 shares. Wright Invsts Serv reported 0.7% stake. Moreover, Carderock Management Incorporated has 2.84% invested in Mastercard Inc (NYSE:MA) for 51,808 shares. Tarbox Family Office accumulated 0.14% or 2,352 shares. Grt Ptnrs Ltd Liability reported 3,836 shares.

More notable recent Mastercard Inc (NYSE:MA) news were published by: Seekingalpha.com which released: “MasterCard: It’s Like Collecting From Your Own Toll Booth” on November 03, 2017, also Gurufocus.com with their article: “RG Niederhoffer Capital Management Inc Buys Mastercard Inc, Tesla Inc …” published on November 06, 2017, Investorplace.com published: “How Mastercard Inc Stacks Up Against Visa Inc Post Earnings” on November 10, 2017. More interesting news about Mastercard Inc (NYSE:MA) were released by: Nasdaq.com and their article: “Earnings Reaction History: MasterCard Inc., 45.5% Follow-Through Indicator, 2 …” published on October 31, 2017 as well as Seekingalpha.com‘s news article titled: “MasterCard’s Results Scream ‘Look At Me!'” with publication date: October 31, 2017.

Among 36 analysts covering Mastercard Incorporated (NYSE:MA), 32 have Buy rating, 0 Sell and 4 Hold. Therefore 89% are positive. Mastercard Incorporated had 89 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Compass Point with “Neutral” on Monday, October 31. The firm has “Buy” rating given on Tuesday, August 25 by Jefferies. Bank of America downgraded the stock to “Neutral” rating in Thursday, February 11 report. Guggenheim upgraded it to “Buy” rating and $153 target in Monday, September 11 report. Wells Fargo initiated Mastercard Inc (NYSE:MA) rating on Wednesday, October 11. Wells Fargo has “Buy” rating and $160.0 target. The company was downgraded on Thursday, July 27 by Credit Suisse. Morgan Stanley maintained the shares of MA in report on Tuesday, September 19 with “Overweight” rating. The firm has “Overweight” rating by JP Morgan given on Wednesday, November 1. On Wednesday, October 11 the stock rating was maintained by Cowen & Co with “Buy”. Cowen & Co maintained Mastercard Inc (NYSE:MA) on Wednesday, September 6 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.